Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02775175
Other study ID # 15-6336-BO
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date October 2016

Study information

Verified date April 2018
Source Universität Duisburg-Essen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study the investigators will test the impact of a modified Ramadan Fasting regimen on health and well-being. The 2016 Ramadan is around summer solstice in Germany making it one of the most challenging fasting periods for participating Muslims. The modified Ramadan Fasting consists of educational components around fasting, and advice for nutritional modifications in order to support health and well-being during Ramadan, while the control group will continue to fast as usual. The investigators will measure not only body weight/fat but also include measures of psychological well-being, and spiritual practice, and serum markers for blood lipids, and blood sugar. With this trial the investigators aim to determine, whether such modifications around Ramadan will be beneficial for health and well-being.


Description:

see above


Recruitment information / eligibility

Status Completed
Enrollment 114
Est. completion date October 2016
Est. primary completion date July 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Healthy Muslims participating in Ramadan Fasting

- No first time fasting

Exclusion Criteria:

- Untreated or malign hypertension

- Eating disorder

- psychological disorder (e.g. depression, schizophrenia, addiction)

- co-morbid disease (e.g. diabetes, cancer, gout)

- pregnancy

- breastfeeding women

- BMI under 20 or above 40

- recently on a diet

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Modified Ramadan Fasting
The intervention aims to provide knowledge about fasting and its effects on the body/mind, and health advice around nutrition to support health and well-being of participants during Ramadan.

Locations

Country Name City State
Germany Department of Internal and Integrative Medicine, Kliniken Essen-Mitte Essen

Sponsors (1)

Lead Sponsor Collaborator
Universität Duisburg-Essen

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Lauche R, Fathi I, Saddat C, Klose P, Al-Abtah J, Büssing A, Rampp T, Dobos G, Cramer H. The effects of Ramadan fasting on physical and mental health in healthy adult Muslims - Study protocol for a randomised controlled trial. Advances in Integrative Medicine, 2016, 3 (1), 26 - 30. doi: 10.1016/j.aimed.2016.07.001

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life Quality of life, measured by the WHO-5 (World Health Organisation, Allgaier et al., 2011, WHO-5, 1998)
WHO-5, Fragebogen zum Wohlbefinden (Version 1998), Psychiatric Research Unit, WHO Collaborating Centre in Mental Health, http://www.who-5.org/.
4 weeks
Secondary Quality of life Quality of life, measured by the WHO-5 (World Health Organisation, Allgaier et al., 2011, WHO-5, 1998)
WHO-5, Fragebogen zum Wohlbefinden (Version 1998), Psychiatric Research Unit, WHO Collaborating Centre in Mental Health, http://www.who-5.org/.
16 weeks
Secondary Satisfaction with life Satisfaction with life, measured by the BMLSS-10 (Brief Multidimensional Life Satisfaction Scale)
Büssing A, Fischer J, Haller A, Heusser P, Ostermann T, Matthiessen PF: Validation of the brief multidimensional life satisfaction scale in patients with chronic diseases. European Journal of Medicine Research 2009; 14: 171-177
4 weeks
Secondary Satisfaction with life Satisfaction with life, measured by the BMLSS-10 (Brief Multidimensional Life Satisfaction Scale)
Büssing A, Fischer J, Haller A, Heusser P, Ostermann T, Matthiessen PF: Validation of the brief multidimensional life satisfaction scale in patients with chronic diseases. European Journal of Medicine Research 2009; 14: 171-177
12 weeks
Secondary Spirituality Spirituality, measured by the SpREUK-P SF17 (Spiritual and Religious Attitudes in Dealing with Illness)
Büssing A, Reiser F, Michalsen A, Baumann K: Engagement of patients with chronic diseases in spiritual and secular forms of practice: Results with the shortened SpREUK-P SF17 Questionnaire. Integrative Medicine: A Clinician´s Journal 2012; 11(1):28-38
4 weeks
Secondary Spirituality Spirituality, measured by the SpREUK-P SF17 (Spiritual and Religious Attitudes in Dealing with Illness)
Büssing A, Reiser F, Michalsen A, Baumann K: Engagement of patients with chronic diseases in spiritual and secular forms of practice: Results with the shortened SpREUK-P SF17 Questionnaire. Integrative Medicine: A Clinician´s Journal 2012; 11(1):28-38
12 weeks
Secondary Sleep quality Sleep quality, measured by the PROMIS Sleep Disturbances and Sleep-related impairment questionnaires
Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med. 2011 Dec 28;10(1):6-24.
4 weeks
Secondary Sleep quality Sleep quality, measured by the PROMIS Sleep Disturbances and Sleep-related impairment questionnaires
Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med. 2011 Dec 28;10(1):6-24.
12 weeks
Secondary Mindfulness Mindfulness, measured by the Conscious Presence and Self Control Instruments
Büssing A, Walach H, Kohls N, Zimmermann F, Trousselard M. Conscious Presence and Self Control as a measure of situational awareness in soldiers - A validation study. International Journal of Mental Health Systems 2013, 7:1
4 weeks
Secondary Mindfulness Mindfulness, measured by the Conscious Presence and Self Control Instruments
Büssing A, Walach H, Kohls N, Zimmermann F, Trousselard M. Conscious Presence and Self Control as a measure of situational awareness in soldiers - A validation study. International Journal of Mental Health Systems 2013, 7:1
12 weeks
Secondary Inner Peace Inner Peace, measured by the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Scale (FACIT-Sp)
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D: Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy - Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002, 24:49-58.
4 weeks
Secondary Inner Peace Inner Peace, measured by the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Scale (FACIT-Sp)
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D: Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy - Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002, 24:49-58.
12 weeks
Secondary Ease of life Ease of life, measured by the Emotional and rational disease acceptance questionnaire (ERDA)
Büssing A, Matthiessen PF, Mundle G. Emotional and rational disease acceptance in patients with depression and alcohol addiction. BMC Health and Quality of Life Outcomes 2008; 6:4.
4 weeks
Secondary Ease of life Ease of life, measured by the Emotional and rational disease acceptance questionnaire (ERDA)
Büssing A, Matthiessen PF, Mundle G. Emotional and rational disease acceptance in patients with depression and alcohol addiction. BMC Health and Quality of Life Outcomes 2008; 6:4.
12 weeks
Secondary Body weight Body weight in kg 4 weeks
Secondary Body weight Body weight in kg 12 weeks
Secondary Body fat Body fat, measured using a Bioelectrical impedance analysis scale 4 weeks
Secondary Body fat Body fat, measured using a Bioelectrical impedance analysis scale 12 weeks
Secondary Waist circumference Waist circumference in cm 4 weeks
Secondary Waist circumference Waist circumference in cm 12 weeks
Secondary Hip circumference Hip circumference 4 weeks
Secondary Hip circumference Hip circumference 12 weeks
Secondary Blood pressure Blood pressure, measured using an automatic device 4 weeks
Secondary Blood pressure Blood pressure, measured using an automatic device 12 weeks
Secondary Heart rate Heart rate, measured using an automatic device 4 weeks
Secondary Heart rate Heart rate, measured using an automatic device 12 weeks
Secondary Compliance Compliance, measured using a structured interview about nutrition during Ramadan 4 weeks
Secondary Adverse events adverse events during the study period 4 weeks
Secondary Blood lipid level Blood lipid level, including serum measures triglycerides, cholesterol, HDL and LDL cholesterol 4 weeks
Secondary Blood glucose level Blood glucose level, serum measure 4 weeks
Secondary AST/SGOT AST/SGOT, as measure of liver function 4 weeks
Secondary ALT/SGPT ALT/SGPT, as measure of liver function 4 weeks
Secondary GGT GGT, as measure of liver function 4 weeks
Secondary Uric acid level Uric acid level, serum measure 4 weeks
Secondary Creatinine Creatinine level, serum measure 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1